ABSTRACT
Purpose
The trial-and-error approach is still predominantly used in pharmaceutical development of nanosuspensions. Physicochemical dispersion stability is a primary focus and therefore, various analytical bulk methods are commonly employed. Clearly less attention is directed to surface changes of nanoparticles even though such interface effects can be of pharmaceutical relevance. Such potential effects in drug nanosuspensions were to be studied for temperatures of 25 and 37°C by using complementary surface analytical methods.
Methods
Atomic force microscopy, inverse gas chromatography and UV surface dissolution imaging were used together for the first time to assess pharmaceutical nanosuspensions that were obtained by wet milling. Fenofibrate and bezafibrate were selected as model drugs in presence of sodium dodecyl sulfate and hydroxypropyl cellulose as anionic and steric stabilizer, respectively.
Results
It was demonstrated that in case of bezafibrate nanosuspension, a surface modification occurred at 37°C compared to 25°C, which notably affected dissolution rate. By contrast, no similar effect was observed in case of fenofibrate nanoparticles.
Conclusions
The combined usage of analytical surface methods provides the basis for a better understanding of phenomena that take place on drug surfaces. Such understanding is of importance for pharmaceutical development to achieve desirable quality attributes of nanosuspensions.
Similar content being viewed by others
Abbreviations
- AFM:
-
Atomic force microscopy
- BF:
-
Bezafibrate
- BFns:
-
Bezafibrate nanosuspension
- DLS:
-
Dynamic light scattering
- DSC:
-
Differential scanning calorimetry
- DWS:
-
Diffusing wave spectroscopy
- FF:
-
Fenofibrate
- FFns:
-
Fenofibrate nanosuspension
- HPC:
-
Hydroxypropyl cellulose
- iGC:
-
Inverse gas chromatography
- ORD:
-
Optical rotatory dispersion
- PXRD:
-
Powder X-ray diffraction
- SDS:
-
Sodium dodecyl sulfate
- SEM:
-
Scanning electron microscopy
- WAXS:
-
Wide angle X-ray scattering
References
Chen H, Khemtong C, Yang X, Chang X, Gao J. Nanonization strategies for poorly water-soluble drugs. Drug Discov Today [Internet]. Elsevier Ltd; 2011;16:354–60. Available from: https://doi.org/10.1016/j.drudis.2010.02.009.
Van Eerdenbrugh B, Van den Mooter G, Augustijns P. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm. 2008;364:64–75.
Lestari MLAD, Müller RH, Möschwitzer JP. Systematic screening of different surface modifiers for the production of physically stable nanosuspensions. J Pharm Sci. 2015;104:1128–40.
George M, Ghosh I. Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology. Eur J Pharm Sci [Internet]. Elsevier B.V.; 2013;48:142–52. Available from: https://doi.org/10.1016/j.ejps.2012.10.004.
Choi JY, Yoo JY, Kwak HS, Nam BU, Lee J. Role of polymeric stabilizers for drug nanocrystal dispersions. Curr Appl Phys. 2005;5:472–4.
Lee MK, Kim S, Ahn C-H, Lee J. Hydrophilic and hydrophobic amino acid copolymers for nano-comminution of poorly soluble drugs. Int J Pharm [Internet]. 2010;384:173–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19788919.
Lee J, Choi JY, Park CH. Characteristics of polymers enabling nano-comminution of water-insoluble drugs. Int J Pharm. 2008;355:328–36.
Goodwin DJ, Sepassi S, King SM, Holland SJ, Martini LG, Lawrence MJ. Characterization of polymer adsorption onto drug nanoparticles using depletion measurements and small-angle neutron scattering. Mol Pharm. 2013;10:4146–58.
Suri GS, Sen T. A recent trend of drug-nanoparticles in suspension for the application in drug delivery. Noaomedicine. 2016;11:2861–76.
Kumar S, Burgess DJ. Wet milling induced physical and chemical instabilities of naproxen nano-crystalline suspensions. Int J Pharm. 2014;466:23–232.
Kayaert P, Van Den Mooter G. Is the amorphous fraction of a dried nanosuspension caused by milling or by drying? A case study with naproxen and cinnarizine. Eur J Pharm Biopharm [Internet]. Elsevier B.V.; 2012;81:650–6. Available from: https://doi.org/10.1016/j.ejpb.2012.04.020.
Otte A, Carvajal MT. Assessment of milling-induced disorder of two pharmaceutical compounds. J Pharm Sci. 2011;100:1793–804.
Egami K, Higashi K, Yamamoto K, Moribe K. Crystallization of probucol in nanoparticles revealed by AFM analysis in aqueous solution. Mol Pharm. 2015;12:2972–80.
Koppel DE. Analysis of macromolecular polydispersity in intensity correlation spectroscopy: the method of cumulants. J Chem Phys [Internet]. 1972;57:4814. Available from: http://scitation.aip.org/content/aip/journal/jcp/57/11/10.1063/1.1678153.
Acad J. Optical properties of hydroxypropycellulose. Macromolecules. 1984;17:1512–20.
Sengupta R, Chakraborty S, Bandyopadhyay S, Dasgupta S, Mukhopadhyay R, Auddy K, et al. A short review on rubber / clay nanocomposites with emphasis on mechanical properties. Engineering [Internet]. 2007;47:21–5. Available from: https://doi.org/10.1002/pen.20921.
Reufer M, Machado AHE, Niederquell A, Bohnenblust K, Müller B, Völker AC, et al. Introducing diffusing wave spectroscopy as a process analytical tool for pharmaceutical emulsion manufacturing. J Pharm Sci. 2014;103:3902–13.
Niederquell A, Völker AC, Kuentz M. Introduction of diffusing wave spectroscopy to study self-emulsifying drug delivery systems with respect to liquid filling of capsules. Int J Pharm. 2012;426:144–52.
Negrini R, Aleandri S, Kuentz M. Study of rheology and polymer adsorption onto drug nanoparticles in pharmaceutical suspensions produced by nano milling. J Pharm Sci [Internet]. 2017. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0022354917305026.
Wyttenbach N, Kirchmeyer W, Alsenz J, Kuentz M. Theoretical considerations of the prigogine-defay ratio with regard to the glass-forming ability of drugs from undercooled melts. Mol Pharm. 2016;13:241–50.
Baird JA, Van Eerdenbrugh B, Taylor LS. A classification system to assess the crystallization tendency of organic molecules from undercooled melts. J Pharm Sci [Internet]. Elsevier Masson SAS; 2010;99:3787–806. Available from: https://doi.org/10.1002/jps.22197.
Niederquell A, Kuentz M. Biorelevant dissolution of poorly soluble weak acids studied by UV imaging reveals ranges of fractal-like kinetics. Int J Pharm [Internet]. Elsevier B.V.; 2014;463:38–49. Available from: https://doi.org/10.1016/j.ijpharm.2013.12.049.
Surana R, Randall L, Pyne A, Vemuri NM, Suryanarayanan R. Determination of glass transition temperature and in situ study of the plasticizing effect of water by inverse gas chromatography. Pharm Res. 2003;20:1647–54.
Yang H, Teng F, Wang P, Tian B, Lin X, Hu X, et al. Investigation of a nanosuspension stabilized by soluplus?? to improve bioavailability. Int J Pharm. 2014;477:88–95.
Malamatari M, Somavarapu S, Taylor KMG, Buckton G. Solidification of nanosuspensions for the production of solid oral dosage forms and inhalable dry powders. Expert Opin Drug Deliv [Internet]. Taylor & Francis; 2016;13:435–50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26764574.
Zuo B, Sun Y, Li H, Liu X, Zhai Y, Sun J. Preparation and in vitro / in vivo evaluation of fenofibrate nanocrystals. Int J Pharm [Internet]. 2013;478:267–75. Available from: https://doi.org/10.1016/j.ijpharm.2013.07.021.
Loh ZH, Samanta AK, Sia Heng PW. Overview of milling techniques for improving the solubility of poorly water-soluble drugs. Asian J Pharm Sci [Internet]. Elsevier Ltd; 2014;10:255–74. Available from: https://doi.org/10.1016/j.ajps.2014.12.006.
Vogt M, Kunath K, Dressman JB. Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations. Eur J Pharm Biopharm. 2008;68:283–8.
Hu J, Ng WK, Dong Y, Shen S, Tan RBH. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying. Int J Pharm. 2011;404:198–204.
Nascimento MLF, Souza LA, Ferreira EB, Zanotto ED. Can glass stability parameters infer glass forming ability? J Non-Cryst Solids. 2005;351:3296–308.
Van Eerdenbrugh B, Baird JA, Taylor LS. Crystallization tendency of active pharmaceutical ingredients following rapid solvent evaporation - classification and comparison with crystallization tendency from undercooled melts. J Pharm Sci. 2010;99:3826–38.
Ke P, Hasegawa S, Al-Obaidi H, Buckton G. Investigation of preparation methods on surface/bulk structural relaxation and glass fragility of amorphous solid dispersions. Int J Pharm [Internet]. Elsevier B.V.; 2012;422:170–8. Available from: https://doi.org/10.1016/j.ijpharm.2011.10.047.
Planinsek O, Zadnik J, Kunaver M, Srcic S, Godec A. Structural evolution of indomethacin particles upon milling: time-resolved quantification and localization of disordered structure studied by IGC and DSC. J Pharm Sci. 2010;99:1968–81.
ACKNOWLEDGMENTS AND DISCLOSURES
Prof. Raffaele Mezzenga is acknowledged for his support to conduct the ORD and WAXS experiments at the ETH in Zurich Switzerland. Author contributions: The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
ESM 1
(DOCX 353 kb)
Rights and permissions
About this article
Cite this article
Aleandri, S., Schönenberger, M., Niederquell, A. et al. Temperature-Induced Surface Effects on Drug Nanosuspensions. Pharm Res 35, 69 (2018). https://doi.org/10.1007/s11095-017-2300-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11095-017-2300-6